1 Min Read
March 5 (Reuters) - Proteon Therapeutics Inc:
* PROTEON THERAPEUTICS COMPLETES ENROLLMENT IN PATENCY-2, PHASE 3 CLINICAL TRIAL OF INVESTIGATIONAL VONAPANITASE Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.